Johnson & Johnson-backed DePuy Synthes completed the acquisition of CrossRoads Extremity Systems.

Johnson & Johnson-backed DePuy Synthes, an orthopaedics company, completed the acquisition of CrossRoads Extremity Systems, a foot and ankle company that provides implants. Financial terms were not disclosed. “At DePuy Synthes, we look at innovation with one goal in mind: to bring differentiated solutions to market to address the unmet needs of surgeons and patients around the world. Healthy feet are a foundational element of overall good health, and we are thrilled about the acquisition of CrossRoads and the opportunity to accelerate meaningful innovation by strengthening our offering for elective foot and ankle procedures, enabling us to provide more comprehensive and leading-edge options to surgeons and patients," Oray Boston, DePuy Synthes President.